Results 111 to 120 of about 86,822 (221)

Budget impact analysis sull’introduzione del dispositivo di telemonitoraggio Turbo+ nella gestione dei pazienti asmatici in Italia. [PDF]

Glob Reg Health Technol Assess, 2022
Rumi F, Basile M, Cicchetti A, Contiguglia R, Pentassuglia A, Oliva A, Senna G, Bonavia M, Scarpelli F, Benvenuto M.   +9 more
europepmc   +1 more source

Recurrent obstructive salivary disease after sialendoscopy. A narrative literature review. [PDF]

Acta Otorhinolaryngol Ital, 2023
Capaccio P, Gaffuri M, Canzi P, Pignataro L.   +3 more
europepmc   +1 more source

Perspective developments of public finance in Italy: a primer [PDF]

The paper outlines the main current issues concerning Public Finance in Italy. It is divided in three parts. The first part discusses the overall budget policy.
Bernardi, Luigi
core   +1 more source

Effectiveness and safety of virtual reality rehabilitation after stroke: an overview of systematic reviews. [PDF]

EClinicalMedicine, 2023
Bargeri S, Scalea S, Agosta F, Banfi G, Corbetta D, Filippi M, Sarasso E, Turolla A, Castellini G, Gianola S.   +9 more
europepmc   +1 more source

Transmeatal microsurgery for intralabyrinthine and intrameatal schwannomas: literature review. [PDF]

Acta Otorhinolaryngol Ital, 2021
Marchioni D, Di Maro F, Presutti L.
europepmc   +1 more source

Premessa [PDF]

, 2011
,
core   +4 more sources

Treatment of relapses of benign latero-cervical pathology: a narrative literature review. [PDF]

Acta Otorhinolaryngol Ital, 2023
Meliante PG, Colizza A, Ralli M, Minni A, Angeletti D, Cambria F, de Vincentiis M.   +6 more
europepmc   +1 more source

Impatto clinico ed economico dell’emicrania in Italia: un’analisi di real-world evidence. [PDF]

Glob Reg Health Technol Assess
Perrone V, Leonetti S, Esposti LD, Giannessi L, Guerzoni S, Entities group.   +5 more
europepmc   +1 more source

Buone pratiche per lo sviluppo dei modelli di budget impact a livello regionale. [PDF]

Glob Reg Health Technol Assess, 2023
Marcellusi A, Ragonese A, Marinozzi A, Bortolami A, Mucherino S, Moreno C, Antenori A, Ferrario M, Simonelli C, Zanuzzi M, Cicoira M, Lasala R, Russoniello F, Attanasio F, Donati C, Roni C, Gemmi F, Mennini FS, Russo P, Scroccaro G, Canonico PL.   +20 more
europepmc   +1 more source

Stima dei pazienti potenzialmente eleggibili alla terapia con icosapent etile in Italia mediante revisione dei dati di letteratura. [PDF]

Glob Reg Health Technol Assess
Filardi PP, Arcangeli E, Carullo P, Galeone C, Arca M.   +4 more
europepmc   +1 more source